Ricia Katherine Hyde

9PUBLICATIONS
62CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)Genome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 18, 2026
The Inv(16) Oncogene CBFB::MYH11 is Required for the Survival of Leukemia Cells in the Blood and Spleen, but not the Bone Marrow.

|Jun 29, 2026
BMX-001 acts as a selective chemoradioprotector in rectal cancer.

|Apr 28, 2026
Tet2 deficiency alters CD4+ T cell function and promotes T cell lymphoma with a TFH cell immunophenotype.

|Mar 27, 2026
PAMD-Ch17, a Polymeric Analog of Plerixafor, Induces Mitochondrial Dysfunction in T-ALL Cells Independent of CXCR4.

Calvin Lam, Arjun Dhir, Arnob Mitro

|Nov 10, 2025
The splicing factor PTBP1 interacts with RUNX1 and is required for leukemia cell survival.

Arjun Dhir, Alexander Ethell, Riley Watkins

|Oct 17, 2025
Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroup.

Waseem G Lone, Jiayu Yu, Xuxiang Liu

Pageof 2

Frequent Collaborators

3 joint publications

Sipra Panda

3 joint publications

Samantha A Swenson

2 joint publications

Waseem Lone

2 joint publications

Xuxiang Liu